Cooperation between IL-7 receptor and integrin α2β1 (CD49b) drives Th17-mediated bone loss

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4198-4209

  El Azreq, Mohammed Amine ^a   Arseneault, Claudie ^a   Boisvert, Marc ^a   Pagé, Nathalie ^a   Allaeys, Isabelle ^a   Poubelle, Patrice E ^a,b   Tessier, Philippe A ^a,b   Aoudjit, Fawzi ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE EROSION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH17 CELL; BONE DEVELOPMENT; CELL ADHESION; CELL POLARITY; ETIOLOGY; LYMPHOCYTE ACTIVATION; OSTEOCLAST; PHYSIOLOGY;

BONE RESORPTION; CELL ADHESION; CELL POLARITY; COLLAGEN; HUMANS; INTEGRIN ALPHA2BETA1; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; OSTEOCLASTS; OSTEOGENESIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN-7; TH17 CELLS;

EID: 84945157727     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500437     Document Type: Article

References (54)

1. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
2. Lubberts, E. 2010. Th17 cytokines and arthritis. Semin. Immunopathol. 32: 43-53.
3. Adamopoulos, I. E., and E. P. Bowman. 2008. Immune regulation of bone loss by Th17 cells. Arthritis Res. Ther. 10: 225-233.
4. Lubberts, E., L. van den Bersselaar, B. Oppers-Walgreen, P. Schwarzenberger, C. J. Coenen-de Roo, J. K. Kolls, L. A. Joosten, and W. B. van den Berg. 2003. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J. Immunol. 170: 2655-2662.
5. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
6. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
7. Yago, T., Y. Nanke, N. Ichikawa, T. Kobashigawa, M. Mogi, N. Kamatani, and S. Kotake. 2009. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J. Cell. Biochem. 108: 947-955.
8. Yago, T., Y. Nanke, M. Kawamoto, H. Yamanaka, and S. Kotake. 2012. Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation. Cytokine 59: 252-257.
9. Dooms, H. 2013. Interleukin-7: Fuel for the autoimmune attack. J. Autoimmun. 45: 40-48.
10. van Roon, J. A., K. A. Glaudemans, J. W. Bijlsma, and F. P. Lafeber. 2003. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 62: 113-119.
11. van Roon, J. A., M. C. Verweij, M. W. Wijk, K. M. Jacobs, J. W. Bijlsma, and F. P. Lafeber. 2005. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum. 52: 1700-1710.
12. Hartgring, S. A., C. R. Willis, J. W. Bijlsma, F. P. Lafeber, and J. A. van Roon. 2012. Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res. Ther. 14: R137.
13. Gendron, S., M. Boisvert, N. Chetoui, and F. Aoudjit. 2008. Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function. Immunology 125: 359-369.
14. Weitzmann, M. N., S. Cenci, L. Rifas, C. Brown, and R. Pacifici. 2000. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96: 1873-1878.
15. Ryan, M. R., R. Shepherd, J. K. Leavey, Y. Gao, F. Grassi, F. J. Schnell, W. P. Qian, G. J. Kersh, M. N. Weitzmann, and R. Pacifici. 2005. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. USA 102: 16735-16740.
16. Salopek, D., D. Grcević, V. Katavić, N. Kovacić, I. K. Lukić, and A. Marusić. 2008. Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter. Immunol. Lett. 121: 134-139.
17. Toraldo, G., C. Roggia, W. P. Qian, R. Pacifici, and M. N. Weitzmann. 2003. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. USA 100: 125-130.
18. Chen, Z., S. J. Kim, N. D. Chamberlain, S. R. Pickens, M. V. Volin, S. Volkov, S. Arami, J. W. Christman, B. S. Prabhakar, W. Swedler, et al. 2013. The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis. J. Immunol. 190: 5256-5266.
19. Toyosaki-Maeda, T., H. Takano, T. Tomita, Y. Tsuruta, M. Maeda-Tanimura, Y. Shimaoka, T. Takahashi, T. Itoh, R. Suzuki, and T. Ochi. 2001. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res. 3: 306-310.
20. Hemler, M. E. 1990. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8: 365-400.
21. Pribila, J. T., A. C. Quale, K. L. Mueller, and Y. Shimizu. 2004. Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 22: 157-180.
22. El Azreq, M. A., and F. Aoudjit. 2014. Collagen-binding integrins in the pathogenesis of rheumatoid arthritis. Austin. J. Clin. Immunol. 1: 1006.
23. Boisvert, M., N. Chetoui, S. Gendron, and F. Aoudjit. 2010. Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells. Eur. J. Immunol. 40: 2710-2719.
24. Chakravarti, A., M. A. Raquil, P. Tessier, and P. E. Poubelle. 2009. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood 114: 1633-1644.
25. Chetoui, N., M. Boisvert, S. Gendron, and F. Aoudjit. 2010. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 130: 418-426.
26. Carrette, F., and C. D. Surh. 2012. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24: 209-217.
27. Timmer, T. C., B. Baltus, M. Vondenhoff, T. W. Huizinga, P. P. Tak, C. L. Verweij, R. E. Mebius, and T. C. van der Pouw Kraan. 2007. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum. 56: 2492-2502.
28. van Roon, J. A., S. A. Hartgring, M. Wenting-van Wijk, K. M. Jacobs, P. P. Tak, J. W. Bijlsma, and F. P. Lafeber. 2007. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Ann. Rheum. Dis. 66: 664-669.
29. Jafri, M., B. Donnelly, S. Allen, A. Bondoc, M. McNeal, P. D. Rennert, P. H. Weinreb, R. Ward, and G. Tiao. 2008. Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G16-G26.
30. Tsunoda, I., E. J. Terry, B. J. Marble, E. Lazarides, C. Woods, and R. S. Fujinami. 2007. Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade. Brain Pathol. 17: 45-55.
31. Ariel, A., E. J. Yavin, R. Hershkoviz, A. Avron, S. Franitza, I. Hardan, L. Cahalon, M. Fridkin, and O. Lider. 1998. IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J. Immunol. 161: 2465-2472.
32. Unsinger, J., M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. 2010. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184: 3768-3779.
33. Ivaska, J., and J. Heino. 2011. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu. Rev. Cell Dev. Biol. 27: 291-320.
34. Benbernou, N., K. Muegge, and S. K. Durum. 2000. Interleukin (IL)-7 induces rapid activation of Pyk2, which is bound to Janus kinase 1 and IL-7Ralpha. J. Biol. Chem. 275: 7060-7065.
35. McGovern, J. L., and C. A. Notley. 2012. Production of IL-17: what's STAT got to do with it? JAKSTAT 1: 80-82.
36. Liu, H., S. Yao, S. M. Dann, H. Qin, C. O. Elson, and Y. Cong. 2013. ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis. Eur. J. Immunol. 43: 1716-1726.
37. Brereton, C. F., C. E. Sutton, S. J. Lalor, E. C. Lavelle, and K. H. Mills. 2009. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 183: 1715-1723.
38. Kurebayashi, Y., S. Nagai, A. Ikejiri, M. Ohtani, K. Ichiyama, Y. Baba, T. Yamada, S. Egami, T. Hoshii, A. Hirao, et al. 2012. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. Cell Reports 1: 360-373.
39. Wan, Q., L. Kozhaya, A. ElHed, R. Ramesh, T. J. Carlson, I. M. Djuretic, M. S. Sundrud, and D. Unutmaz. 2011. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J. Exp. Med. 208: 1875-1887.
40. Tokoyoda, K., S. Zehentmeier, A. N. Hegazy, I. Albrecht, J. R. Grün, M. Löhning, and A. Radbruch. 2009. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30: 721-730.
41. Hanazawa, A., K. Hayashizaki, K. Shinoda, H. Yagita, K. Okumura, M. Löhning, T. Hara, S. Tani-ichi, K. Ikuta, B. Eckes, et al. 2013. CD49b-dependent establishment of T helper cell memory. Immunol. Cell Biol. 91: 524-531.
42. Nemoto, Y., T. Kanai, M. Takahara, S. Oshima, T. Nakamura, R. Okamoto, K. Tsuchiya, and M. Watanabe. 2013. Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells. Gut 62: 1142-1152.
43. Gendron, S., J. Couture, and F. Aoudjit. 2003. Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J. Biol. Chem. 278: 48633-48643.
44. Page, G., and P. Miossec. 2005. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum. 52: 2307-2312.
45. Ammon, C., S. P. Meyer, L. Schwarzfischer, S. W. Krause, R. Andreesen, and M. Kreutz. 2000. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100: 364-369.
46. Edelson, B. T., Z. Li, L. K. Pappan, and M. M. Zutter. 2004. Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin. Blood 103: 2214-2220.
47. Mambole, A., S. Bigot, D. Baruch, P. Lesavre, and L. Halbwachs-Mecarelli. 2010. Human neutrophil integrin alpha9beta1: up-regulation by cell activation and synergy with beta2 integrins during adhesion to endothelium under flow. J. Leukoc. Biol. 88: 321-327.
48. Stange, R., D. Kronenberg, M. Timmen, J. Everding, H. Hidding, B. Eckes, U. Hansen, M. Holtkamp, U. Karst, T. Pap, and M. J. Raschke. 2013. Age-related bone deterioration is diminished by disrupted collagen sensing in integrin α2β1 deficient mice. Bone 56: 48-54.
49. Uemura, T., Y. K. Liu, and Y. Kuboki. 2000. Preliminary communication. MRNA expression of MT1-MMP, MMP-9, cathepsin K, and TRAP in highly enriched osteoclasts cultured on several matrix proteins and ivory surfaces. Biosci. Biotechnol. Biochem. 64: 1771-1773.
50. Takayanagi, H., S. Kim, and T. Taniguchi. 2002. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res. 4(Suppl. 3): S227-S232.
51. Gao, Y., F. Grassi, M. R. Ryan, M. Terauchi, K. Page, X. Yang, M. N. Weitzmann, and R. Pacifici. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117: 122-132.
52. Jin, J. O., T. Kawai, S. Cha, and Q. Yu. 2013. Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice. Arthritis Rheum. 65: 2132-2142.
53. Boisvert, M., S. Gendron, N. Chetoui, and F. Aoudjit. 2007. Alpha2 beta1 integrin signaling augments T cell receptor-dependent production of interferon-gamma in human T cells. Mol. Immunol. 44: 3732-3740.
54. El Azreq, M. A., M. Boisvert, A. Cesaro, N. Pagé, L. Loubaki, I. Allaeys, J. Chakir, P. E. Poubelle, P. A. Tessier, and F. Aoudjit. 2013. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. J. Immunol. 191: 5941-5950.